Analystreport

TherapeuticsMD (TXMD) was downgraded by Weiss Ratings from "hold (c-)" to "sell (d-)".

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com